ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1963

Fracture Sites, Frequencies and Causes in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study

Kensuke Ochi1, Takefumi Furuya2, Eisuke Inoue3, Katsunori Ikari4, Atsuo Taniguchi3, Shigeki Momohara4 and Hisashi Yamanaka2, 1Department of Orthopaedic Surgery, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 3Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 4Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Fractures and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Although rheumatoid arthritis (RA) is a risk factor for osteoporosis and fracture, limited data exist in the literature concerning fracture site and frequency in patients with RA. We previously reported clinical risk factors for both incident vertebral and nonvertebral fractures in Japanese RA patients using our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort study. Herein we expanded our previous study to evaluate fracture sites, frequencies, and causes in Japanese RA patients.

Methods: The IORRA is a prospective observational cohort study of Japanese RA patients at the Institute of Rheumatology, Tokyo Women’s Medical University (Tokyo, Japan) that was started in 2000. A total of 9,720 patients (82% female; mean age, 56 years) with RA were enrolled in the IORRA cohort study from 2000 to 2010. All participants self-reported whether they had a fracture event within the previous 6 months, the site of fracture (ankle, arm, cervical spine, clavicle, elbow, femoral neck, foot, hand, knee, leg, nose, pelvis, rib, shoulder, thoracic spine, lumbar spine, wrist, and others), and the reasons for fracture (accident, fall, spontaneous event, or sports injury) every 6 months from October 2000 to October 2010. We then analyzed the sites, frequencies, and causes of the fractures to clarify the epidemiology of fractures in Japanese RA patients.

Results: During a mean (SD) duration of 5.2 (3.3) years, 1357 patients reported a total of 2076 incident fractures. Among them, 837 (61.7%) reported a single fracture, 520 (38.3%) reported two fractures, 303 (22.3%) reported three fractures, and 217 (16.0%) reported more than three fractures. Overall, 287 (13.8%) vertebral fractures and 1789 (86.2%) nonvertebral fractures (head: n=35, 1.7%; trunk: n=504, 24.3%; upper limb: n=508, 24.5%; and lower limb: n=742, 35.7%) were reported. The most frequent fresh nonvertebral fracture was rib (n=368, 20.6%), followed by toe (n=276, 15.4%), femoral neck (n=178, 9.9%), ankle (n=132, 7.4%), wrist (n=122, 6.8%), hand (n=117, 6.5%), shoulder (n=105, 5.9%), arm (n=86, 4.8%), knee (n=84, 4.7%), elbow (n=78, 4.4%), pelvis (n=71, 4.0%), leg (n=57, 3.2%), clavicle (n=56, 3.1%), and head including nose (n=35, 2.0%). Causes of overall fractures were fall in 55.5% of patients, followed by spontaneous events in 33.2%, accident in 7.8%, and sports injury in 1.0%; the major causes of vertebral fractures were spontaneous events (63.5%) and fall (27.4%), while fall (60.0%) and spontaneous events (28.3%) were the major causes of nonvertebral fractures.

Conclusion: Fourteen percent of Japanese patients with RA reported one or more incident fractures within a mean duration of 5.2 years. Unlike non-RA elderly subjects, spontaneous events were a major cause of fractures. Differences between RA patients and non-RA subjects should be at least in some part due to the significant osteoporosis seen in RA patients.


Disclosure:

K. Ochi,
None;

T. Furuya,
None;

E. Inoue,
None;

K. Ikari,
None;

A. Taniguchi,
None;

S. Momohara,
None;

H. Yamanaka,

Abbott Japan Co. Ltd.,

5,

AstraZeneca K.K.,

5,

Bristol-Myers Squibb,

5,

Chugai Pharmaceutical Co. Ltd.,

5,

Eisai Co. Ltd.,

5,

Janssen Pharmaceutical K.K. Japan,

5,

Mitsubishi Tanabe Pharma Corporation,

5,

Pfizer Japan Inc.,

5,

Takeda Pharmaceutical Co. Ltd.,

5,

Teijin Pharma Limited,

5,

UCB Japan Co. Ltd.,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fracture-sites-frequencies-and-causes-in-9720-japanese-patients-with-rheumatoid-arthritis-a-prospective-observational-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology